181 related articles for article (PubMed ID: 25034486)
1. Therapy of acute and fulminant hepatitis B.
Tillmann HL; Patel K
Intervirology; 2014; 57(3-4):181-8. PubMed ID: 25034486
[TBL] [Abstract][Full Text] [Related]
2. Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
Colle I; Adler M; Brenard R; Henrion J; Langlet P; Michielsen P; Orlent H; Reynaert H; Sprengers D; Stärkel P; Van Damme P; Verslype C; Delwaide J;
Acta Gastroenterol Belg; 2007; 70(4):389-420. PubMed ID: 18330099
[No Abstract] [Full Text] [Related]
3. [Acute hepatitis B: is antiviral therapy indicated? Two case reports].
Girke J; Wedemeyer H; Wiegand J; Manns MP; Tillmann HL
Dtsch Med Wochenschr; 2008 May; 133(22):1178-82. PubMed ID: 18491273
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
[TBL] [Abstract][Full Text] [Related]
5. [Protocol for the antiviral therapy of hepatitis B and D].
; ; Gervain J; Horváth G; Hunyady B; Makara M; Pár A; Szalay F; Tornai I; Telegdy L
Orv Hetil; 2010 Jan; 151(1):24-8. PubMed ID: 20031523
[No Abstract] [Full Text] [Related]
6. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatitis B virus reinfection in liver transplant recipients.
Roche B; Samuel D
Intervirology; 2014; 57(3-4):196-201. PubMed ID: 25034488
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
Chan HL; Wong VW; Tse AM; Tse CH; Chim AM; Chan HY; Wong GL; Sung JJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1462-8. PubMed ID: 18054753
[TBL] [Abstract][Full Text] [Related]
9. [Drug therapy of hepatitis B and C].
Färkkilä M
Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
[No Abstract] [Full Text] [Related]
10. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pegylated interferon-α2a in chronic hepatitis B patients demonstrating a spontaneous decline in HBV DNA after acute exacerbation.
Cai Q; Chen F; Shao X; Zhang X; Zhao Z; Gao Z
Antivir Ther; 2015; 20(2):217-24. PubMed ID: 25138110
[TBL] [Abstract][Full Text] [Related]
12. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
[TBL] [Abstract][Full Text] [Related]
13. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
Buster EH; Schalm SW; Janssen HL
Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
[TBL] [Abstract][Full Text] [Related]
14. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
Tillmann HL; Zachou K; Dalekos GN
Liver Int; 2012 Apr; 32(4):544-53. PubMed ID: 22099371
[TBL] [Abstract][Full Text] [Related]
15. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
Janssen HL; Sonneveld MJ; Brunetto MR
Gut; 2012 May; 61(5):641-5. PubMed ID: 22180061
[No Abstract] [Full Text] [Related]
16. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
[TBL] [Abstract][Full Text] [Related]
17. Prevention of recurrent hepatitis B post-liver transplantation.
Lok AS
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S67-73. PubMed ID: 12362302
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of hepatitis B virus infection].
Trautwein C
Praxis (Bern 1994); 2006 Sep; 95(36):1389-97. PubMed ID: 16989182
[TBL] [Abstract][Full Text] [Related]
19. Predicting treatment outcomes for HBV patients.
AIDS Patient Care STDS; 2009 Mar; 23(3):223. PubMed ID: 19480059
[No Abstract] [Full Text] [Related]
20. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
